Atherosclerotic Cardiovascular Disease (ASCVD), Chronic Kidney Disease (CKD)
Conditions
Brief summary
This is a survey-based study with the objective to understand the awareness, perceptions and potential clinical management patterns among Chinese cardiologists and nephrologists towards the role of systemic inflammation in patients with ASCVD and CKD in real-world clinical setting.
Interventions
OTHERNo treatment given
Online self-completion survey
Sponsors
Novo Nordisk A/S
Study design
Observational model
COHORT
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Work in cardiology, internal medicine, or nephrology department * Specialize in one of the following: coronary interventional cardiology, HF, general cardiology, preventive cardiology, cardiac rehabilitation or nephrology * Practice at consultant level for 3+ years after standardized training for resident physicians or 3+ years' working experience as a specialist * Manage at least 20 adult patients with ASCVD and CKD (not dialysis-only) every month
Exclusion criteria
* Unwilling to provide informed consent * Insufficient number of patients with ASCVD and CKD * Do not fulfil inclusion criteria.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Health care professional's perceptions towards the role of systemic inflammation in the identification, treatment and management of patients with ASCVD and CKD | At the time of survey response (Day 1) | Multi-select from a defined list; Single-select from a defined list; Numerical; 7-point Likert scale for measurement of agreement to different statements from 1 strongly disagree to 7 strongly agree |
Countries
China
Outcome results
None listed